Dietary Supplements
Vitamins, botanicals, functional ingredients, and supplement products governed by market-specific ingredient, claims, notification, and safety rules.
Foresight tracks Dietary Supplements developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.
Not ready for a trial? Take the 3-minute readiness assessment
Current activity
Cooling
49% below the prior 8-week baseline
3-month trend
Latest alerts below
Last updated
13 May 2026, 11:58
Latest Dietary Supplements alerts
The most recent regulatory and guidance signals tracked by Foresight
EFSA NDA Issues Opinion on Safety of Beta-Nicotinamide Mononucleotide (β-NMN) as a Novel Food for Adult Food Supplements
In May 2026 EFSA's NDA Panel concluded that chemically synthesised beta-nicotinamide mononucleotide (β-NMN) is safe as a novel food ingredient in adult food supplements at doses up to 300 mg per day, providing a bioavailable source of niacin under the EU novel foods and food supplements frameworks. This scientific opinion sets a clear safety benchmark for forthcoming EU authorisation decisions and gives supplement manufacturers an evidence-based intake limit and specification profile for any β-NMN products targeting the European market.
Ukraine: Order No. 203 Tightens Dietary Supplement Composition and Health-Claim Rules (In Force 17 April 2026)
In April 2026 Ukraine’s Ministry of Health brought into force Order No. 203, tightening the compositional, labelling and health-claim rules for dietary supplements and for the addition of vitamins, minerals and certain other substances to foods. Manufacturers and importers of supplements and fortified foods now face clear upper limits for key nutrients, new bans and restrictions on certain ingredients and stricter marketing constraints, requiring prompt reviews of product formulas, labelling and claims for all products placed on the Ukrainian market.
US FDA Announces Recall of Better Weather Fix Elixir Dietary Supplements for Undeclared Mitragynine and Mitragynine Pseudoindoxyl
In May 2026, the US FDA announced a voluntary recall of Better Weather Fix Elixir dietary supplements after testing found undeclared mitragynine and the more potent mitragynine pseudoindoxyl in approximately 448 boxes of product. This highlights regulatory and liability risks for companies marketing kratom-related or other pharmacologically active ingredients as dietary supplements without transparent labelling and robust ingredient controls.
US FDA Warns Against RAPTURE Preworkout With Hidden DMAA Ingredient
In May 2026 the US FDA warned that RAPTURE Preworkout, a dietary supplement sold online and in some stores, contains undeclared DMAA and should not be used. This underscores regulators’ focus on hidden drug ingredients in supplements and signals higher expectations for manufacturers, distributors, and retailers around product testing, labelling, and rapid response to safety findings.
US FDA Warns RAPTURE Preworkout Contains Hidden DMAA
US FDA has warned that the RAPTURE Preworkout dietary supplement contains an undeclared stimulant (DMAA) and issued a health fraud notification advising consumers not to purchase or use it. This underscores intensified enforcement focus on dietary supplements and preworkout products that conceal drug-like ingredients, heightening compliance and liability risk for brands using aggressive performance claims.
Delaware HB 394 Would Prohibit Sale of Energy Drinks and Caffeinated Dietary Supplements to Minors
In April 2026, Delaware lawmakers proposed HB 394, a bill that would ban retailers from selling energy drinks and caffeinated dietary supplements to individuals under 18 while leaving possession and consumption by minors legal. If enacted, the law would take effect one year after enactment, requiring convenience stores and other beverage and supplement retailers in Delaware to tighten age controls on high-caffeine products sold to minors.
Taiwan TFDA Promotes Voluntary GMP System for Health Supplements
Taiwan’s Food and Drug Administration is promoting a voluntary GMP system for health supplement manufacturers, built on 2020 guidelines and inspection-based certification to align production with international standards. While not legally mandatory, this scheme creates a de facto quality benchmark for Taiwanese supplement suppliers and can support market access and risk assurance for overseas customers relying on documented manufacturing controls.
Brazil Chamber Approves Urgency Regime for Dietary Supplements Control Bill PL 5229/2025
In April 2026 Brazil’s Chamber of Deputies approved an urgency regime for PL 5229/2025, a bill that would overhaul sanitary control of dietary supplements and related enforcement tools. If enacted, this package could move quickly to impose stricter Anvisa registration, testing, labelling, e-commerce and recall obligations on supplement manufacturers and retailers, making early compliance planning and monitoring of the plenary vote critical.
EU PAFF General Food Law Committee Publishes May 2026 Agendas on Monacolins and Garcinia Cambogia Supplements
The European Commission’s PAFF General Food Law committee has published May 2026 agendas highlighting a French safeguard ban on Garcinia cambogia food supplements and an EU draft regulation to amend Annex III of Regulation (EC) No 1925/2006 on monacolins from red yeast rice. These meetings signal possible changes to conditions of use for specific food supplement ingredients at both national and EU level, creating reformulation and market-access risks that manufacturers and importers should track closely.
Brazil Anvisa Orders Recall of Counterfeit Intimate Lubricants and Vitafor Supplements
In April 2026, Brazil’s Anvisa ordered recall, seizure, and prohibition measures against counterfeit K Med intimate lubricants and falsified Vitafor food supplements sold via Shopee after confirming they differed materially from genuine products and were of unknown origin. These actions signal heightened enforcement against falsified consumer health products in Brazil, meaning manufacturers, distributors, and online platforms must tighten supplier verification and product traceability or risk sudden withdrawals, reputational damage, and sanctions.
China SAMR Consults on Adding Lycopene to Health Food Ingredients Catalogue
China’s market regulator has issued a draft health food ingredients catalogue entry to add lycopene and opened a public consultation running until 10 May 2026. If adopted, this will formalise conditions for using lycopene in Chinese health foods, influencing formulation choices, claim strategies, and filing routes for supplement brands.
Brazil Anvisa Updates Turmeric Supplement Limits and Labelling
Brazil’s health regulator Anvisa has issued a new Normative Instruction tightening permitted dose ranges and mandatory warnings for turmeric (Curcuma longa) food supplements after identifying potential liver risks. Manufacturers and importers now have six months to reformulate affected products, ensure curcuminoid levels sit within new minimum–maximum limits, and implement the specific liver-risk label warning to remain compliant in the Brazilian market.
UK Adds Magnesium L‑threonate Monohydrate to Permitted Mineral Sources for Food Supplements
The UK has adopted The Nutrition (Amendment etc.) (EU Exit) (Amendment) Regulations 2026, allowing magnesium L‑threonate monohydrate as a new permitted source of magnesium in food supplements in England from 12 August 2026. This opens additional formulation options for supplement manufacturers, who should review product development, sourcing, and labelling strategies in light of the updated nutrition regulations and General Food Law obligations.
Norway Mattilsynet and Forbrukertilsynet Issue Joint Guidance on Dietary Supplement Labelling and Subscription Marketing
In March 2026, Norway's food and consumer authorities issued a joint guidance letter to over 300 dietary supplement businesses clarifying the rules for labelling, health claims and subscription-based marketing. This signals tighter scrutiny of supplement advertising and online subscription practices in Norway, and companies selling into this market should review their claims, pricing disclosures and contract terms to avoid enforcement action.
US Congress Introduces HB8370 Dietary Supplement Listing Act of 2026
In April 2026, the Dietary Supplement Listing Act of 2026 (H.R. 8370) was introduced in the US House to amend the Federal Food, Drug, and Cosmetic Act and require manufacturers to list dietary supplements with the FDA. If enacted, this would create a new federal listing and transparency obligation for dietary supplement manufacturers, likely driving portfolio reviews, data gathering, and closer alignment of product information with regulatory expectations.
France Renews Ban on Garcinia Cambogia Dietary Supplements (Arrêté of 16 April 2026)
On 16 April 2026 France renewed a ministerial order suspending the import, introduction and marketing of dietary supplements containing the plant Garcinia cambogia and preparations derived from it. This keeps an existing ban in force, so supplement manufacturers and distributors must continue to exclude Garcinia cambogia products from their French portfolios and adjust sourcing and formulations accordingly.
California Assembly Committee Advances AB 2779 on Dietary Supplement Date Labelling to Appropriations
In April 2026, a California Assembly committee advanced AB 2779, which would exclude dietary supplements from the state’s new food date-labelling rules and re-referred the bill to the Appropriations Committee. If enacted, this change would reduce date-labelling obligations for supplement manufacturers and retailers in California while leaving the broader food date-labelling framework intact and signalling ongoing legislative fine-tuning rather than a wholesale policy shift.
Japan CAA Convenes Subcommittee Meeting on Regulatory Framework for Supplements
Japan’s Consumer Affairs Agency has released a discussion paper and convened a 23 April 2026 expert meeting to examine a new regulatory framework for supplements, including a working definition and stronger GMP-based manufacturing controls. This marks a significant pre-proposal step toward tighter supplement oversight under the Food Sanitation Act, so supplement manufacturers and importers should monitor outcomes and prepare for potential mandatory GMP and product-definition changes in the Japanese market.
Korea MFDS Publishes Functional Ingredient Monograph for Banaba Leaf Extract
In March 2026, Korea’s Ministry of Food and Drug Safety published a technical monograph consolidating safety and functional evidence for Banaba leaf extract as a health functional food ingredient. This gives manufacturers and ingredient suppliers a clear MFDS reference point for using Banaba leaf extract in Korean health functional foods, supporting dossier preparation, claim justification, and alignment with future re-evaluation outcomes.
New York Assembly Introduces Synthetic Kratom Kills Act (A10969)
New York has introduced Assembly Bill A10969, the Synthetic Kratom Kills Act, to ban synthetic and adulterated kratom products while imposing strict testing, packaging, labelling, and age-limit rules on natural kratom sales. If enacted, kratom manufacturers and retailers serving New York would need to overhaul product formulations, quality-control, and compliance programmes to meet new contaminant limits, alkaloid-testing, warnings, and enforcement-backed penalties.
Not a newsletter. Not a feed.
Structured intelligence mapped to your business.
These are just a few of the most recent Dietary Supplements alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.
Start free trialFrequently asked questions
Everything you need to know about Foresight's regulatory intelligence platform
Still have questions? Get in touch with our team
Join 3,500+ professionals staying ahead
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at